Willis C. Lee

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Torrance, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
Willis C. Lee
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Willis C. Lee

Form 4 holding Co-President & COO, Director

Emmaus Life Sciences, Inc.

Security class
Common stock, $0.001 par value
Shares / value
395,124
Estimated value
$51,366
Report date
26 Feb 2024
Price
$0.1300
Ownership
Direct
Form 4 holding Co-President & COO, Director

Emmaus Life Sciences, Inc.

Security class
Common stock, $0.001 par value
Shares / value
241,194
Estimated value
$31,355
Report date
26 Feb 2024
Price
$0.1300
Ownership
By Fidelity Traditional IRA FBO Willis C. Lee
Form 4 holding Co-President & COO, Director

Emmaus Life Sciences, Inc.

Security class
Options
Shares / value
200,000
Estimated value
$30,000
Report date
01 Feb 2024
Price
$0.1500
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Co-President & COO, Director

Emmaus Life Sciences, Inc.

Security class
Common stock, $0.001 par value
Shares / value
159,400
Estimated value
$20,722
Report date
29 Feb 2024
Price
$0.1300
Ownership
By Fidelity Roth IRA FBO Willis C. Lee

Insider Reports Filed by Willis C. Lee

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .